Search

Your search keyword '"Cordon-Cardo, Carlos"' showing total 72 results

Search Constraints

Start Over You searched for: Author "Cordon-Cardo, Carlos" Remove constraint Author: "Cordon-Cardo, Carlos" Publisher springer science and business media llc Remove constraint Publisher: springer science and business media llc
72 results on '"Cordon-Cardo, Carlos"'

Search Results

1. The DACH1 gene is frequently deleted in prostate cancer, restrains prostatic intraepithelial neoplasia, decreases DNA damage repair, and predicts therapy responses

2. Development and validation of an AI-enabled digital breast cancer assay to predict early-stage breast cancer recurrence within 6 years

3. circCsnk1g3- and circAnkib1-regulated interferon responses in sarcoma promote tumorigenesis by shaping the immune microenvironment

4. Antemortem detection of Parkinson’s disease pathology in peripheral biopsies using artificial intelligence

6. Molecular evidence of SARS-CoV-2 in New York before the first pandemic wave

8. Convalescent plasma treatment of severe COVID-19: a propensity score–matched control study

9. Author Correction: A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer

10. An inflammatory cytokine signature predicts COVID-19 severity and survival

11. Author Correction: Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate

12. Author Correction: Intragenic antagonistic roles of protein and circRNA in tumorigenesis

13. Intragenic antagonistic roles of protein and circRNA in tumorigenesis

14. EMT- and stroma-related gene expression and resistance to PD-1 blockade in urothelial cancer

15. Development and validation of a novel automated Gleason grade and molecular profile that define a highly predictive prostate cancer progression algorithm-based test

17. Erratum: Corrigendum: mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer

18. An aberrant SREBP-dependent lipogenic program promotes metastatic prostate cancer

19. Erratum: The metabolic co-regulator PGC1α suppresses prostate cancer metastasis

20. mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer

21. PTEN counteracts FBXL2 to promote IP3R3- and Ca2+-mediated apoptosis limiting tumour growth

24. The metabolic co-regulator PGC1α suppresses prostate cancer metastasis

25. Metabolic reprogramming induces resistance to anti-NOTCH1 therapies in T cell acute lymphoblastic leukemia

26. Massive parallel sequencing uncovers actionable FGFR2–PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma

27. Bladder cancers arise from distinct urothelial sub-populations

28. A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia

29. Zbtb7a suppresses prostate cancer through repression of a Sox9-dependent pathway for cellular senescence bypass and tumor invasion

30. A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer

35. The TLX1 oncogene drives aneuploidy in T cell transformation

36. Erratum: Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence

37. Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence

38. PHF6 mutations in T-cell acute lymphoblastic leukemia

39. Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate

40. ETS rearrangements and prostate cancer initiation

41. γ-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia

42. Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia

43. Tissue-specific and reversible RNA interference in transgenic mice

44. The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomas

49. Gene expression profiling in single cells within tissue

Catalog

Books, media, physical & digital resources